KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Dr. Michael Kauffman on Q2 2019 Results - Earnings Call Transcript
Karyopharm Therapeutics Inc. (KPTI)
Q2 2019 Earnings Conference Call
August 6, 2019 8:30 A.M. ET
Company Participants
Ian Karp - Vice President, Investor and Public Relations
Dr. Michael Kauffman - Chief Executive Officer
Perry Monaco - Senior Vice President, Sales
Mike Mason - Chief Financial Officer
Christopher Primiano - Chief Business Officer and General Counsel
Conference Call Participants
Brian Abrahams - RBC Capital Markets
Arlinda Lee - Canaccord
Jonathan Chang - SVB Leerink
Mike Ulz - Baird
Ed White - H.C. Wainwright
Presentation
Operator
Good morning. My name is Skyler and I will be your